Regulation & law · 29/11/2002Updated: 10/17/2026 · 1 min read
NIH Considers Exclusive License for Conjugate Vaccines Against Nontypeable Haemophilus Influenzae and Moraxella Catarrhalis
Summary
The National Institutes of Health is contemplating the grant of an exclusive license to Apovia, Inc. for the development of conjugate vaccines against diseases caused by nontypeable Haemophilus influenzae and Moraxella catarrhalis, particularly otitis media.